These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 21804588)

  • 21. Individual responder analyses for pain: does one dose fit all?
    Mather LE
    Trends Pharmacol Sci; 2005 Nov; 26(11):544-5. PubMed ID: 16165226
    [No Abstract]   [Full Text] [Related]  

  • 22. An audience with... Tachi Yamada. Interviewed by Asher Mullard.
    Yamada T
    Nat Rev Drug Discov; 2013 Sep; 12(9):658-9. PubMed ID: 23989787
    [No Abstract]   [Full Text] [Related]  

  • 23. An audience with… Steve Blank. Interview by Asher Mullard.
    Blank S
    Nat Rev Drug Discov; 2014 Aug; 13(8):570. PubMed ID: 25082282
    [No Abstract]   [Full Text] [Related]  

  • 24. Paul Stoffels. Interview by Asher Mullard.
    Stoffels P
    Nat Rev Drug Discov; 2013 Apr; 12(4):258. PubMed ID: 23535929
    [No Abstract]   [Full Text] [Related]  

  • 25. An audience with... Susan Desmond-Hellmann. Interview by... Asher Mullard.
    Desmond-Hellmann S
    Nat Rev Drug Discov; 2011 Mar; 10(3):170. PubMed ID: 21358729
    [No Abstract]   [Full Text] [Related]  

  • 26. The private sector's role in public sector genetically engineered crop projects.
    Potrykus I
    N Biotechnol; 2010 Nov; 27(5):578-81. PubMed ID: 20637908
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An open study of botulinum-A toxin treatment of trigeminal neuralgia.
    Zakrzewska JM; Cohen J; Brown J; Alksne J; Gemillion H; Linskey M; Sirois D; Pollock B
    Neurology; 2006 May; 66(9):1458-9; author reply 1458-9. PubMed ID: 16685762
    [No Abstract]   [Full Text] [Related]  

  • 28. The precompetitive space: time to move the yardsticks.
    Norman T; Edwards A; Bountra C; Friend S
    Sci Transl Med; 2011 Mar; 3(76):76cm10. PubMed ID: 21451121
    [TBL] [Abstract][Full Text] [Related]  

  • 29. What can we learn from failed neuropathic pain trials?
    Polydefkis M; Raja SN
    Neurology; 2008 Jan; 70(4):250-1. PubMed ID: 18209199
    [No Abstract]   [Full Text] [Related]  

  • 30. [Clinical study of antalgic drugs].
    Dubray C
    Therapie; 1999; 54(1):135-45. PubMed ID: 10216437
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical trials in rheumatology: asking the relevant question.
    Weintraub M
    J Rheumatol; 1979; 6(4):365-9. PubMed ID: 522090
    [No Abstract]   [Full Text] [Related]  

  • 32. Alan Aderem. Interview with Asher Mullard.
    Aderem A
    Nat Rev Drug Discov; 2011 Jul; 10(7):486. PubMed ID: 21720398
    [No Abstract]   [Full Text] [Related]  

  • 33. Pros and cons of Public Private Partnerships.
    Blake N
    Aust Nurs J; 2004 Mar; 11(8):15. PubMed ID: 19157390
    [No Abstract]   [Full Text] [Related]  

  • 34. Comments on Migraleve trial reports.
    Merrington DM
    Curr Ther Res Clin Exp; 1975 Jul; 18(1 pt 2):222-5. PubMed ID: 809238
    [No Abstract]   [Full Text] [Related]  

  • 35. [Drug research by the family physician in general and particularly of the analgetic diflunisal].
    Offerhaus L
    Ned Tijdschr Geneeskd; 1980 Apr; 124(14):516-9. PubMed ID: 7374814
    [No Abstract]   [Full Text] [Related]  

  • 36. [French biomedical competitiveness clusters: opportunities for public-private partnerships].
    Vasmant D
    Bull Acad Natl Med; 2009 Dec; 193(9):2035-43; discussion 2044. PubMed ID: 20666016
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dan Tagle. Interview by Asher Mullard.
    Nat Rev Drug Discov; 2013 Nov; 12(11):822. PubMed ID: 24172326
    [No Abstract]   [Full Text] [Related]  

  • 38. The motivations for participation in public-private partnerships for the provision of tuberculosis treatment in South Africa.
    Sinanovic E; Kumaranayake L
    Glob Public Health; 2010; 5(5):479-92. PubMed ID: 19479590
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Joe selby. Interview by Asher Mullard.
    Selby J
    Nat Rev Drug Discov; 2011 Aug; 10(9):652. PubMed ID: 21878972
    [No Abstract]   [Full Text] [Related]  

  • 40. The Role of Public-Private Partnerships in Catalyzing the Critical Path.
    Maxfield KE; Buckman-Garner S; Parekh A
    Clin Transl Sci; 2017 Nov; 10(6):431-442. PubMed ID: 28776943
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.